Activation of human vascular endothelial cells by factor Xa: Effect of specific inhibitors

Biochemical Pharmacology

Volumn 57, Issue 6, 1999, Pages 603-610

  Herault, Jean Pascal ^a   Bono, Françoise ^a   Avril, Corinne ^a   Schaeffer, Paul ^a   Herbert, Jean Marc ^a  

^a SANOFI   (France)

Author keywords

Calcium; Endothelial cells; Factor Xa; PAI 1; Proliferation; Tissue factor; TPA

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; IDRAPARINUX; PENTASACCHARIDE; PHOSPHATIDYLINOSITIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; UMBILICAL VEIN;

ANTICOAGULANTS; CALCIUM; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FACTOR XA; FIBRINOLYTIC AGENTS; HUMANS; NAPHTHALENES; OLIGOSACCHARIDES; PHOSPHATIDYLINOSITOLS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROPIONIC ACIDS; THROMBOPLASTIN;

EID: 0033560119     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00348-7     Document Type: Article

References (29)

1. Sugo T., Nakamikawa C., Tanabe S., Matsuda M. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells - Its catalytic efficiency is similar to that of prothrombinase complex on platelets. J Biochem. 117:1995;244-250.
2. Pearson JD, The control of production and release of haemostatic factors in the endothelial cell. In: Baillière's Clinical Haematology (Ed. Baillière T) 6: 629-651, 1993.
3. Rodgers G.M., Shuman M.A. Characterization of the interaction between factor Xa and bovine aortic endothelial cells. Biochim Biophys Acta. 844:1985;320-329.
4. Mc Gee M.P., Rothberger H. Assembly of the prothrombin activator complex on rabbit alveolar macrophage high-affinity factor Xa receptors. J Exp Med. 164:1986;1902-1914.
5. Tracy P.B., Eide L.L., Mann K.G. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem. 260:1985;2119-2124.
6. Altieri D.C. Xa receptor EPR-1. FASEB J. 9:1995;860-865.
7. Altieri D.C., Edgington T.S. Identification of effector cell protease receptor-1 a leukocyte-distributed receptor for the serine protease factor Xa . J Immunol. 145:1990;246-253.
8. Bouchard B.A., Catcher C.S., Thrash B.R., Adida C., Tracy P.B. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem. 272:1997;9244-9251.
9. Kasama K., Komiyama J., Kiesel W. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood. 81:1993;676-682.
10. Sakai T., Kiesel W. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. J Biol Chem. 265:1990;9105-9113.
11. Stern D.M., Nawroth P.P., Kiesel W., Drillings D., Bartos J. A coagulation pathway on bovine aortic segments leading to generation of factor Xa and thrombin. J Clin Invest. 74:1984;1910-1921.
12. Ambrosini G., Altieri D.C. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. J Biol Chem. 271:1996;1243-1248.
13. Bono F., Herault J.P., Avril C., Schaeffer P., Herbert J.M. Human umbilical vein endothelial cells express high affinity receptors for factor Xa. J Cell Physiol. 172:1997;36-43.
14. Nicholson A.C., Nachman R.L., Altieri D.C., Summers B.D., Ruf W., Edgington T.S., Hajjar D.P. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem. 271:1996;28407-28413.
15. Papapetropoulos A., Piccardoni P., Cirino G., Bucci M., Sorrentino R., Cicala C., Johnson K., Zachariou V., Sessa W.C., Altieri D. Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA. 95:1998;4738-4742.
16. Van Boeckel C.A.A., Petitou M. The unique antithrombin III binding domain of heparin A lead to new synthetic antithrombotics . Angew Chem Int Ed Engl. 32:1993;1671-1818.
17. Herbert J.M., Bernat A., Dol F., Hérault J.P., Crépon B., Lormeau J.C. DX9065a, a novel, synthetic, selective and orally active inhibitor of factor Xa. In vitro and in vivo studies. J Pharmacol Exp Ther. 276:1996;1030-1038.
18. Grynkiewicz G., Poenie M., Tsien R.J. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
19. Berridge M., Dawson C., Downes C., Heslop C., Irvine R. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J. 212:1983;473-482.
20. Surprenant Y.M., Zuckerman S.H. A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophage and endothelial cells. Thromb Res. 53:1989;339-342.
21. Emeis J., Kooistra T. Interleukin-1 and lipopolysaccharide induce a fast-acting inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med. 163:1986;1260-1267.
22. Van Hinsberg V.M.G., Kooistra T., Van den Bergh E.A., Princen H.M.G., Fiers W., Emeis J.J. TNF increases the production of PAI in human endothelial cells in vitro and rats in vivo. Blood. 72:1988;1467-1473.
23. Herbert J.M., Lamarche I., Dol F.I. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor - Effect of heparin. FEBS Lett. 301:1992;155-158.
24. Mirza H., Yatsuia V., Bahou W.F. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest. 97:1996;1705-1714.
25. Carmeliet P., Collen D. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice. Thromb Haemost. 10:1996;195-213.
26. Annamalai A.E., Stewart G.J., Hansel B., Memoli M., Chiu H.C., Manuel D.W., Doshi K., Colman R.W. Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury. Atherosclerosis. 6:1985;196-202.
27. Jenny R.J., Pittman D.D., Hritz R.W., Aldape R.A., Hewick R.M., Kaufman R.J., Mann K.G. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA. 84:1987;4846-4850.
28. Weitz J.I., Hudoba M., Massel D., Maraganore J., Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest. 86:1990;385-391.
29. Schaeffer P., Mares A.M., Dol F., Bono F., Herbert J.M. Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta. Circ Res. 81:1997;824-828.